External radiation therapy for endometrial carcinoma: The University Hospital of Ioannina experience

Purpose of investigation: The aim of our study was to present the experience of our department in the treatment of endometrial cancer with postoperative external beam radiotherapy (EBRT) without intracavitary brachytherapy (BRT) and to evaluate the efficacy of such a method.

Methods: We retrospectively retrieved the medical records of all patients with endometrial cancer treated with surgery and EBRT alone (median dose 50.0 Gy). Thirty-one women (median age: 67 years) of all clinical stages were reviewed and analyzed for recurrences (local or metastases) and late post-radiation side-effects.

Results: Within a median follow-up of 17 months one patient developed local recurrence and four developed metastases. Overall survival was 97% and disease-free survival was 87%. Three women developed post-radiation colitis. No other treatment-related late side-effects were observed.

Conclusion: EBRT without BRT achieved an excellent local control in women with endometrial cancer although some of them were candidates for supplementary BRT.

Endometrial cancer; External radiotherapy

[1] Salvesen H.B., Akslen L.A.: "Molecular pathogenesis and prognostic factors in endornetrial carcinoma". APMIS, 2002, 110 (10), 673.

[2] Ayhan A., Taskiran C., Celik C., Aksu T., Yuce K.: "Surgical stage III endornetrial cancer: analysis of treatment outcomes, prognostic factors and failure patterns". Eur. J. Gynaecol. Oneal., 2002, 23 (6), 553.

[3] Mariani A., Webb M.J., Keeney G.L., Lesnick T.G., Podratz K.C.: "Surgical Stage I endornetrial cancer: predictors of distant failure and death". Gynecol. Oneal., 2002, 87 (3), 274.

[4] Rose P.G.: "Endornetrial carcinoma". N. Engl. J. Med., 1996, 335, 640.

[5] Ohkouchi T., Sakuragi N., Watari H., Nomura E., Todo Y., Yamada H. et al.: "Prognostic significance of Bcl-2, p53 overexpression, and lymph node metastasis in surgically staged endornetrial carcinorna". Arn. J. Obstet. Gynecol., 2002, 187 (2), 353.

[6] Pitson G., Colgan T., Levin W., Lockwood G., Manchul L., Milosevic M. et al.: "Stage II endornetrial carcinoma: prognostic factors and risk classification in 170 patients". Int. J. Radial Oneal. Biol. Phys., 2002, 53 (4), 862.

[7] Mang山G., De Marzi P., Vigano R., Rabaiotti E., Sassi I., Taccagni G.L. et al.: "Identification of high risk patients with endometrial carcinoma. Prognostic assessment of endornetrial cancer". Eur. J. Gynaecol. Oneal., 2002, 23 (3), 216.

[8] Poulsen M.G., Roberts S.J.: "Prognostic variables in endometrial carcinoma". Int. J. Radial. Oneal. Biol. Phys., 1987, 13, 1043.

[9] Yalrnan D., Ozsaran Z., Anacak Y., Celik O.K., Ozkok S., Ozsaran A. et al.: "Postoperative radiotherapy in endometrial carcinoma: analysis of prognostic factors in 440 cases". Eur. J. Gynaecol. Oncol., 2000, 21 (3), 311.

[10] Kodama S., Kase H., Tanaka K., Matsui K.: "Multivariate analysis of prognostic factors in patients with endornetrial cancer". Int. J. Gynaecol. Obstet., 1996, 53 (1), 23.

[11] Carey M.S., O'Connell G.J., Johanson C.R., Goodyear M.D., Murphy K.J., Daya D.M. et al.: "Good outcome associated with a standardized treatment protocol using selective postoperative radiation in patients with clinical stage I adenocarcinorna of the endometrium". Gynecol. Oneal., 1995, 57 (2), 138.

[12] Shepherd J.H.: "Revised FIGO staging for gynaecological cancer". Br. J. Obstet. Gynaecol., 1989, 96 (8), 889.

[13] Chen S.S.: "Operative treatment in Stage I endometrial carcinoma with deep myometrial invasion and/or grade 3 tumor surgically limited to the corpus uteri. No recurrence with only primary surgery". Cancer, 1989, 63 (9), 1843.

[14] Larson D.M., Broste S.K., Krawisz B.R.: "Surgery without rad10- therapy for primary treatment of en dome trial cancer". Obstet. Gynecol., 1998, 91 (3), 355.

[15] Ayhan A., Taskiran C., Celik C., Guney I., Yuce K., Ozyar E. et al.: "Is there a survival benefit to adjuvant radiotherapy in highrisk surgical Stage I endometrial cancer?". Gynecol. Oneal., 2002, 86 (3), 259.

[16] Weiss M.F., Connell P.P., Waggoner S., Rotmensch J., Mundt A.J.: "External pelvic radiation therapy in Stage IC endometrial carcinoma". Obstet. Gynecol., 1999, 93 (4), 599.

[17] Rush S., Gal D., Potters L., Bosworth J., Lovecchio J.: "Pelvic control following external beam radiation for surgical Stage I endometrial adenocarcinoma". Int. J. Radial. Oneal. Biol. Phys., 1995, 33 (4), 851.

[18] Torrisi J.R., Barnes W.A., Popescu G., Whitfield G., Barter J., Lewandowski G. et al.: "Postoperative adjuvant external-beam radiotherapy in surgical Stage I endometrial carcinoma". Cancer, 1989, 64 (7), 1414.

[19] Bliss P., Cowie V.J.: "Endometrial carcinoma: does the addition of intracavitary vault caesium to external beam therapy postoperatively result in improved control or increased morb心ty?". Clin Oneal. (R. Coll. Radio!.), 1992, 4 (6), 373.

[20] Algan O., Tabesh T., Hanlon A., Hogan W.M., Boente M., Lanciano R.M.: "Improved outcome in patients treated with postoperalive radiation therapy for pathologic stage I/II endometrial cancer". Int. J. Radiat. Oneal. Biol. Phys., 1996, 35 (5), 925.

[21] Weiss E., Hirnle P., Arnold-Bofinger H., Hess C.F., Bamberg M.: 'Therapeutic outcome and relation of acute and late side effects in the adjuvant radiotherapy of endometrial carcinoma Stage I and II". Radiother. Oneal., 1999, 53 (1), 37.

[22] Jereczek-Fossa B.A.: "Postoperative irradiation in endometrial cancer: still a matter of controversy". Cancer Treat. Rev., 2001, 27 (1), 19.